NX1011

· NITROX, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NX1011, covering 2007-08-30 to 2007-08-30. Get the full timeline:

Most recent: Clinical Trial Update: Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial Hypertension [Phase 2]